Journal of Thyroid Cancer · Editorial Board
Editorial Board
The JTC editorial board brings together researchers and clinicians working across thyroid oncology. The editors below work across the disciplines the journal covers — pathology and cytology, imaging, surgery, nuclear medicine, endocrinology, molecular diagnostics and cancer epidemiology — and manuscripts are assigned to the editor who works in the area the manuscript addresses.
01 · Editorial leadership
Editor-in-Chief
02 · The board
Editorial board members
Each entry gives the member’s name, role, institution, country and recorded expertise, and links the ORCID record where the member publishes one. Members are listed in the journal’s own order; nothing on this page ranks them.
-
Marcos Santos Editorial Board Senior Director - Scientific Operations, Diaceutics, Global, São Paulo · Brazil Thyroid Nodules, Molecular Diagnostics ORCID 0000-0002-4108-8649 -
Pamela Pinzani Editorial Board University of Florence · Italy molecular biology, clinical chemistry, oncology, Liquid Biopsy, Circulating Tumor Cells, Single Cell Analysis ORCID 0000-0003-4017-3574 -
Frederik Anton Verburg Editorial Board Senior physician, Clinic for Nuclear Medicine, Department of Nuclear Medicine · Germany Radiology, Surgery, Otolaryngology, Plastic Surgery, Neuroradiology, Oral and Maxillofacial Surgery, Oncology, Internal Medicine (General Medicine). -
Byeong-Cheol Ahn Editorial Board Professor, Kyungpook National University Hospital, Daegu · South Korea Radiology, Neuroradiology, Oncology, Hematology, Hepatology, Radiochemistry, Nuclear Chemistry, Medicinal Chemistry. ORCID 0000-0001-7700-3929 -
Esther Diana Rossi, MD, PhD, MIAC Editorial Board Division of Anatomic Pathology and Histology Università Cattolica del Sacro Cuore, Agostino Gemelli School of Medicine and Hospital, Largo Francesco Vito 1, Rome · Italy Anatomic Pathology and Histology. -
Hong Wu Editorial Board Department of Ultrasound, Jiang Yuan Hospital Affiliated with the Jiangsu Institute of Nuclear Medicine. (Key Laboratory of Nuclear Medicine, Ministry of Health/Jiangsu Key Laboratory of Molecular Nuclear Medicine) · China thyroid; parathyroid; ultrasound; FNA. -
Mahdi Fallah Editorial Board Visiting Professor in Medical (Clinical) Epidemiology, Lund University, Malmo · Sweden Personalized Cancer Prevention, Familial Cancer, Epidemiology, Cancer, Preventive Oncology ORCID 0000-0002-6639-065X -
Mario Vitale Editorial Board Full Professor, University of Salerno, Salerno · Italy Diabetes and Metabolism, General Endocrinology, Endocrinological Oncology, Thyroid. ORCID 0000-0002-4583-5971 -
Ruth Casey Editorial Board Consultant Endocrinologist, Cambridge University Hospitals NHS Foundation Trust, Cambridge, England · United Kingdom adrenal, genomics, neuroendocrine tumours ORCID 0000-0003-4058-3135 -
Vladimir Pushkarev Editorial Board Head of Laboratory, Institute of Endocrinology and Metabolism, Kiev · Ukraine endocrinology, carcinogenesis, diabetes. ORCID 0000-0003-0347-7771 -
Zakaria Abd Elmageed Editorial Board Associate Professor of Pharmacology, Edward Via College of Osteopathic Medicine, Blacksburg, VA · United States Therapeutic targets, cancer biology, exosomes, micrornas, cancer progression ORCID 0000-0003-4031-0348 -
Giuseppe Di Benedetto Editorial Board Cytopathology Service, ASL Caserta, Department of Clinical Pathology · Italy Cytopathology, Thyroid Cancer and BRAF mutation, Cyto Morphometry and Histopathology. -
Iwao Sugitani Editorial Board Nippon Medical School Musashi Kosugi Hospital, Kawasaki, Kanagawa · Japan Surgery & research of thyroid cancer ORCID 0000-0001-5560-0706 -
Manas Sahoo Editorial Board Dr.Manas Kumar Sahoo, MD, Consultant, Nuclear Medicine & PET/CT, Medanta-The Medicity, Gurugram, India-122001 · India Recent advancement of in thyroid cancer PET/CT in thyroid cancer
03 · Subject coverage
How the board covers the journal’s scope
The research areas below are the core domains set out in the journal’s aims and scope. The links highlight members working across these areas; each profile provides the member’s current recorded research interests.
- Tumor biology and molecular pathogenesis
- Pamela Pinzani · Vladimir Pushkarev · Zakaria Abd Elmageed
- Cytopathology and histopathology
- Esther Diana Rossi, MD, PhD, MIAC · Giuseppe Di Benedetto · Hong Wu
- Molecular diagnostics and biomarkers
- Marcos Santos · Pamela Pinzani · Giuseppe Di Benedetto · Ruth Casey
JTC is recruiting editors in systemic and targeted therapy for thyroid carcinoma. Clinicians and researchers working in kinase-directed treatment, redifferentiation or immunotherapy who would like to join the board are invited to write to the editorial office.
04 · Governance
How editorial decisions are made
Editorial independence
Editorial decisions are based on scope, scientific quality, methodological rigor, ethical compliance, reporting quality, and relevance to the journal. Reviewers advise; the decision is the editor's, and it is taken independently of any fee, membership, service or role.
Assignment by subject
Handling editors are assigned by subject rather than by rota, so a manuscript is read by an editor who works in the area it addresses.
Competing interests and recusal
An editor who has an interest in a manuscript - institutional, financial or personal - takes no part in its assessment. Funding sources, grant numbers and competing interests are declared by every author.
Manuscripts authored by editors
Editors who publish in the journal are handled by another editor, and their authorship is disclosed on the published article. An editor never handles, reviews or decides their own manuscript.
Confidentiality
Submitted manuscripts are confidential. Reviewers must not retain or use unpublished material, and after submitting a review they should securely delete downloaded manuscript files.
Peer review
All submissions undergo initial editorial screening. Manuscripts that meet the journal's scope and minimum requirements proceed to independent peer review. Single-blind by default; double-blind review is available on request.
Where to go next
Read on
The board is one of several things an author weighs. These pages answer the rest.
Journal of Thyroid Cancer (JTC) · ISSN 2574-4496 · Crossref DOI prefix 10.14302 · published open access by Open Access Pub under CC BY 4.0, with copyright retained by authors. Editorial decisions are independent of any fee, service, membership or role.